Patents by Inventor Meenakshi Venkatraman

Meenakshi Venkatraman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20080108656
    Abstract: The present invention provides compounds of the formula: and pharmaceutically acceptable isomers, salts, hydrates, solvates, and prodrug derivatives thereof, wherein R1, R6, R7, R8, Pg, and n are those defined herein. The present invention also provides pharmaceutical compositions comprising the same and methods for using the same. In particular, compounds of Formula I are useful in modulating TGF-? activity.
    Type: Application
    Filed: November 16, 2007
    Publication date: May 8, 2008
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Anjali Pandey, Robert Scarborough, Meenakshi Venkatraman
  • Publication number: 20070142408
    Abstract: This invention provides compounds that are useful for treating patients having a TGF-?-mediated disease, particularly an ALK5-mediated disease. The compounds are represented by formula I: wherein: a-b is CH2CH2, CH2CH2CH2, CH?CH, CH?N, or N?CH; Z is N or C—F; and G is C1-6 aliphatic or a phenyl, naphthyl, or 5-6 membered heteroaryl ring.
    Type: Application
    Filed: January 16, 2007
    Publication date: June 21, 2007
    Inventors: Robert Scarborough, Anjali Pandey, Meenakshi Venkatraman
  • Publication number: 20060069093
    Abstract: Substituted benzoxazin-4(3H)-ones are provided which are useful for treating thrombosis and for reducing the likelihood and/or severity of a secondary ischemic event in a patient.
    Type: Application
    Filed: September 26, 2005
    Publication date: March 30, 2006
    Applicant: Portola Pharmaceuticals, Inc.
    Inventors: Robert Scarborough, Meenakshi Venkatraman, Xiaoming Zhang, Anjali Pandey
  • Publication number: 20050032835
    Abstract: The present invention provides compounds of the formula: and pharmaceutically acceptable isomers, salts, hydrates, solvates, and prodrug derivatives thereof, wherein R1, R6, R7, R8, Pg, and n are those defined herein. The present invention also provides pharmaceutical compositions comprising the same and methods for using the same. In particular, compounds of Formula I are useful in modulating TGF-? activity.
    Type: Application
    Filed: June 15, 2004
    Publication date: February 10, 2005
    Applicant: Millennium Pharmaceuticals, Inc.
    Inventors: Anjali Pandey, Robert Scarborough, Meenakshi Venkatraman